Treatment of Early Symptomatic Alzheimer Disease With Valacyclovir
To the Editor We read with great interest the recent study reporting that valacyclovir treatment in individuals with early symptomatic Alzheimer disease was associated with greater cognitive decline compared with placebo. This was an unexpected and thought-provoking finding that challenges prevailing expectations.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.